Navigation Links
McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products:

* concentrated Tylenol(R) Infants' Drops Plus Cold

* concentrated Tylenol(R) Infants' Drops Plus Cold and cough

* PediaCare(R) Infant Drops products

FORT WASHINGTON, Pa., Oct. 11 /PRNewswire/ -- McNeil Consumer Healthcare, a division of McNeil-PPC, Inc., announced today that the company is voluntarily withdrawing certain infants' cough and cold products from the market. When used as directed, these medicines are generally recognized as safe and effective. While most parents use these medicines appropriately and follow dosing directions, an assessment of available data on the use of pediatric cough and cold medicines has identified rare instances of misuse leading to overdose, particularly in infants under 2 years of age.

McNeil Consumer Healthcare is withdrawing Concentrated Infants' TYLENOL(R) Drops Plus Cold; Concentrated Infants' TYLENOL(R) Drops Plus Cold & Cough; PEDIACARE(R) Infant Drops Decongestant (PSE); PEDIACARE(R) Infant Drops Decongestant & Cough (PSE); PEDIACARE(R) Infant Dropper Decongestant (PE); PEDIACARE(R) Infant Dropper Long-Acting Cough; and PEDIACARE(R) Infant Dropper Decongestant & Cough (PE) products from the U.S. market.

Cough and cold products for children age two and over and single- ingredient pain reliever/fever reducers expressly labeled for infants are not included in this voluntary withdrawal and remain available for parents and caregivers.

"This voluntary action by McNeil Consumer Healthcare is based on the company's long-standing commitment to the appropriate use of medications by parents and physicians," said Ashley McEvoy, President, McNeil Consumer Healthcare. "McNeil Consumer Healthcare is committed to providing parents with safe and effective over-the-counter medications that treat their child's cough and cold symptoms. In addition to taking this voluntary action, McNeil Consumer Healthcare, along with our industry partners, supports the Consumer Healthcare Products Association recommendations that were recently submitted to the U.S. Food and Drug Administration (FDA). These recommendations include label changes to OTC cough and cold medicines advising 'do not use' in children under 2 years of age. Our voluntary action in removing Concentrated Infants' TYLENOL(R) Drops Plus Cold; Concentrated Infants' TYLENOL(R) Drops Plus Cold & Cough; and PEDIACARE(R) Infant Drops products from the market is consistent with these recommendations."

The recommendations that were submitted by the Consumer Healthcare Products Association are intended to help reduce misuse leading to overdose by further promoting the appropriate use of OTC cough and cold medicines in children for relief of their symptoms and by further encouraging communication between parents and their doctors. In addition to the label change recommendations for OTC cough and cold medicines, the submission also reinforces the industry's continued commitment to working with the FDA and pediatric experts to ensure that parents and doctors have appropriate treatment choices for their children through ongoing educational and scientific efforts.

Consumers or retailers who have questions or concerns about the products described in this communication should contact McNeil's Consumer Relationship Center at 1-877-895-3665 (English) or 1-888-466-8746 (Spanish) or visit

McNeil Consumer Healthcare Division of McNeil-PPC, Inc. markets a broad range of well-known and trusted over-the-counter (OTC) products around the globe. McNeil Consumer Healthcare is most widely recognized for the complete line of TYLENOL(R) acetaminophen products, the leading pain reliever brand in the adult and pediatric categories. The TYLENOL(R) product line consists of hundreds of products across a variety of pain categories including: arthritis pain, pain with accompanying sleeplessness and upper respiratory. Other McNeil Consumer Healthcare brands include BENADRYL(R) allergy medicines; IMODIUM(R) A-D anti-diarrheal; MOTRIN(R) IB; PediaCare(R) upper respiratory medicines for children; ROLAIDS(R) antacid products; ST. JOSEPH(R) Adult Regimen Aspirin; and SUDAFED(R) and SUDAFED PE(R) nasal decongestants.

SOURCE McNeil Consumer Healthcare
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
2. Iodex goes to SmithKline Beecham consumer Healthcare
3. Consumer group seeks Sibutramine ban
4. Identifying What Consumers Look For On Food Stuff Labels
5. Consumers Becoming More Health Conscious Than Calorie Conscious
6. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
7. Consumers of soft drinks to be more alert
8. Consumers Worried About Trans-Fats The Most
9. New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand
10. Health care system “Consumer friendly” by 207
11. Chocolate makers to be health wise and urge consumers to be too!
Post Your Comments:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
Breaking Medicine Technology: